• No results found

Regenerative medicine in cardiovascular disease: from tissue enginering to tissue regeneration Grauss, R.W.

N/A
N/A
Protected

Academic year: 2021

Share "Regenerative medicine in cardiovascular disease: from tissue enginering to tissue regeneration Grauss, R.W."

Copied!
2
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

Regenerative medicine in cardiovascular disease: from tissue enginering to tissue regeneration

Grauss, R.W.

Citation

Grauss, R. W. (2008, January 17). Regenerative medicine in cardiovascular disease: from tissue enginering to tissue regeneration. Retrieved from https://hdl.handle.net/1887/12556

Version: Corrected Publisher’s Version

License: Licence agreement concerning inclusion of doctoral thesis in the Institutional Repository of the University of Leiden Downloaded

from: https://hdl.handle.net/1887/12556

Note: To cite this publication please use the final published version (if applicable).

(2)

Regenerative Medicine in Cardiovascular Disease:

From Tissue Engineering to Tissue Regeneration

Robert W. Grauss Regenerative Medicine in Cardiovascular Disease:From Tissue Engineering to Tissue Regeneration Robert W. Grauss

Referenties

GERELATEERDE DOCUMENTEN

Peripheral blood cells were stained with HLA-A2.1 tetramers containing the tyrosinase368–376 peptide followed by staining with a panel of lineage antibodies, as described in

Blades and blade fragments seem to have been especially used for longitudinal motions, mainly on plant material (7/12). Flake and flake fragments are used in different motions on

This shape also occurs in the combination artefacts (see below). The shape is the result of intensive use in a repetitive abrasive motion, carried out from different angles. In

Figure 4: Schematic pressure-volume loops (based on mean end-diastolic and end-systolic pressures and volumes) obtained by conduct- ance catheter in sham-operated mice without

• Mesenchymal stem cells from patients with ischemic heart disease can engraft in the inf- arcted mouse myocardium and preserve LV function 2 weeks after acute myocardial infarction,

In Hoofdstuk 5 hebben we de haalbaarheid van het gebruik van humane mesenchymale stam- cellen (hMSC) uit patiënten met ischemische hartziekten (IHD) als celtherapie voor het acute

Adult Mesenchymal Stem Cells from patients with Ischemic Heart Disease improve left ventricular function after acute Myocardial Infarction in NOD/scid mice:.. functional analysis

Humane mesenchymale stamcellen uit beenmerg van patiënten met ischemische hart- ziekten kunnen zich nestelen in het geïnfarceerde muizenhart en de linkerventrikelfunctie